Primary anetoderma associated with antiphospholipid antibodies and micromorphologic vascular lesions: Case report and literature review

Acta Dermatovenerologica Croatica

Volumn 13, Issue 3, 2005, Pages 177-183

  Radoš, Jaka ^a   Dobrić, Ivan ^a   Drvar, Daniela Ledić ^a   Lončarić, Davorin ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Anetoderma; Antiphospholipid antibodies; Antiphospholipid syndrome

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANETODERMA; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; BLOOD VESSEL INJURY; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LITERATURE; MALE; MICROMORPHOLOGY; PATHOGENESIS; REVIEW; THROMBOCYTOPENIA;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ATROPHY; DERMIS; HUMANS; MALE;

EID: 27744492342     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Maari C, Powell J. Atrophies of connective tissue. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. Edinburgh, London: Mosby; 2003. p. 1540-2.
2. Benest L, Kwark E, Goldwasser J, Dantzig P, Weinberg JM, Davis I. Primary anetoderma. Cutis 2000;65:188-90.
3. Ponnighaus JM, Jaeger G, Baum HP. Anetodermie Schhweninger-Buzzi auf dunkler Haut. Hautartzt 2001;52:950-1.
4. Özkan S, Fetil E, Îzler F, Pabucçuoǧlu U, Yalçin N, Güneş AT. Anetoderma secondary to generalized granuloma annulare. J Am Acad Dermatol 2000;442:335-8.
5. Crone AM, James MP. Acquired linear anetoderma following angular cheilitis. Br J Dermatol 1998;138:923-4.
6. Schepis C, Siragusa M. Secondary anetoderma in people with Down's syndrome. Acta Derm Venereol (Stockh) 1999;79:245-51.
7. Shalders K, Ilchyshyn A, Walzman M. Secondary anetoderma following molluscum contagiosum infection. Acta Derm Venereol 2003;83:461-2.
8. Bauer J, Leitz G, Palmedo G, Hügel H. Anetoderma: another facet of Lyme disease? J Am Acad Dermatol 2003;48:S86-88.
9. Carr RD. Urticaria pigmentosa associated with anetoderma. Acta Derm Venereol (Stockh) 1971;51:120-2.
10. Ang P, Tay YK. Anetoderma in a patient with juvenile xanthogranuloma. Br J Dermatol 1999;140:541-2.
11. Fujioka M, Gozo N, Osamu M, Tsuneyuki Y, Takehisa Y. Secondary anetoderma overlying pilomatrixomas. Dermatology 2003;207:316-8.
12. Venencie PY, Winkelmann RK. Histopathologic findings in anetoderma. Arch Dermatol 1984;120:1040-4.
13. Gerritsen MJ, de Rooij MJ, Sybrandy-Fleuren BA, van de Kerkhof PCM. Familial anetoderma. Dermatology 1999;198:321-2.
14. Peterman A, Scheel M, Sams M Jr., Pandya AG. Hereditary anetoderma. J Am Acad Dermatol 1996;35:999-1000.
15. Prizant TL, Lucky AW, Frieden IJ, Burton PS, Suarez SM. Spontaneous atrophic patches in extremely premature infants. Arch Dermatol 1996;132:671-4.
16. Zellman GL, Levy ML. Congenital anetoderma in twins. J Am Acad Dermatol 1997;36:483-5.
17. Ghomrasseni S, Dridi M, Gogly B, Bonnefoix M, Vabres P, Venencie PY, et al. Anetoderma: an altered balance between metalloproteinases and tissue inhibitors of metalloproteinases. Am J Dermatopathol 2002;24:118-29.
18. Sparsa A, Piette JC, Wechsler B, Amoura Z, Francès C. Anetoderma and its prothrombotic abnormalities. J Am Acad Dermatol 2003;49:1008-12.
19. Hodak E, Shamai-Lubovitz O, David M, Hazaz B, Katzenelson-Weissman V, Lahav M, et al. Immunologic abnormalities associated with primary anetoderma. Arch Dermatol 1992;128:799-803.
20. Hodak E, Shamai-Lubovitz O, David M, Hazaz B, Lahav M, Sandbank M. Primary anetoderma associated with a wide spectrum of autoimmune abnormalities. J Am Acad Dermatol 1991;25:415-8.
21. Álvarez-Cuesta CC, Raya-Aguado C, Fernández-Rippe ML, Sánchez TS, Pérez-Oliva N. Anetoderma in a systemic lupus erythematosus patient with anti-PCNA and antiphospholipid antibodies. Dermatology 2001;203:348-50.
22. Hodak E, Feuerman H, Molad Y, Monselise Y, David M. Primary anetoderma: a cutaneous sign of antiphospholipid antibodies. Lupus 2003;12:564-8.
23. Bilen N, Bayramgürler D, Şikar A, Erçin C, Yilmaz A. Anetoderma associated with antiphospholid syndrome and systemic lupus erythematosus. Lupus 2003;12:714-6.
24. Disdier P, Harlé JR, Andrac L, Verrot D, Bolla G, San Marco M, et al. Primary anetoderma associated with the antiphospholipid syndrome. J Am Acad Dermatol 1994;30:133-4.
25. Ruiz-Rodriguez R, Longaker M, Berger TG. Anetoderma and human immunodeficiency virus infection. Arch Dermatol 1992;128:661-2.
26. Lindstrom J, Smith KJ, Skelton HG, Redfield R, Alving BM, Wagner KF, et al. Increased anticardiolipin antibodies associated with the development of anetoderma in HIV-1 disease. Int J Dermatol 1995;34:408-15.
27. Gezer S. Antiphospholipid syndrome. Dis Mon 2003;49:691-742.
28. Gibson GE, Su DW, Pittelkov MR. Antiphospholipid syndrome and the skin. J Am Acad Dermatol 1997;36:970-82.
29. Iverson GM, Victoria EJ, Cockerill KA, Linnik MD. Advances in understanding what we measure when detecting anticardiolipin auto-antibodies. Clin Chim Acta 2004;343:37-44.
30. Stephansson EA, Niemi KM, Jouhikauinen T, Vaarala O, Palosuo T. Lupus anticoagulant and the skin: a long term follow up study of SLE patients with special reference to histopathological findings. Acta Derm Venereol (Stockh) 1991;71:416-22.
31. Roubey RA. New approaches to prevention of thrombosis in the antiphospholipid syndrome: hopes, trials and tribulations. Arthritis Rheum 2003;48:3004-8.
32. Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 1992;117:997-1002.